Krishna Kumar Dhakchinamoorthi: How AI-Powered Technologies Analyze Patient History to Detect and Predict DVT
Krishna Kumar Dhakchinamoorthi, Professor and Head at SNS Institutions, shared a post on LinkedIn:
“Artificial Intelligence (AI) is transforming the prevention, diagnosis, and management of Deep Vein Thrombosis (DVT) by enabling faster detection and smarter clinical decision-making.
This infographic illustrates how AI-powered technologies analyze patient history, Doppler ultrasound images, laboratory reports, and vital signs to identify blood clots and predict DVT risk at an early stage.
It highlights the role of machine learning, wearable health monitoring, and clinical decision support systems in improving patient safety and treatment outcomes.
The infographic also emphasizes key benefits such as early diagnosis, accurate risk prediction, timely intervention, continuous monitoring, and personalized patient care.
Through advanced digital healthcare solutions, AI is helping healthcare professionals reduce complications, prevent pulmonary embolism, and improve overall vascular health management.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery